Skip to main content
. 2024 Apr 25;19(4):e0302300. doi: 10.1371/journal.pone.0302300

Table 2. Characteristics of patients with dementia based on polypharmacy status.

Characteristics Dementia Polypharmacy (5+) Excessive polypharmacy (10+)
n % n % P-value* n % P-value**
Total 57,346 (100.0) 40,318 (100.0)   13,581 (100.0)  
Sex Male 18,344 (32.0) 12,829 (31.8) 0.1825 4,622 (34.0) <0.0001
Female 39,002 (68.0) 27,489 (68.2)   8,959 (66.0)  
Age 60–64 2,125 (3.7) 1,288 (3.2) <0.0001 395 (2.9) <0.0001
65–69 3,603 (6.3) 2,352 (5.8) 759 (5.6)
70–74 6,619 (11.5) 4,649 (11.5) 1,688 (12.4)
75–79 13,124 (22.9) 9,674 (24.0) 3,560 (26.2)
80–84 16,724 (29.2) 12,106 (30.0) 4,154 (30.6)
85–89 12,219 (21.3) 8,351 (20.7) 2,521 (18.6)
90–91 2,932 (5.1) 1,898 (4.7)   504 (3.7)  
Disability Severe 5,286 (9.2) 3,687 (9.1) <0.0001 1,327 (9.8) <0.0001
Mild 10,675 (18.6) 8,008 (19.9) 3,122 (23.0)
None 41,385 (72.2) 28,623 (71.0)   9,132 (67.2)  
Region Seoul-Metro 21,743 (37.9) 15,469 (38.4) 0.0180 4,966 (36.6) <0.0001
Chungcheong 7,319 (12.8) 5,101 (12.7) 1,658 (12.2)
Honam 9,493 (16.6) 6,638 (16.5) 2,556 (18.8)
Gyeongsang 15,828 (27.6) 11,040 (27.4) 3,740 (27.5)
Gangwon-Jeju 2,963 (5.2) 2,070 (5.1)   661 (4.9)  
Income level Medical Aid 8,452 (14.7) 6,369 (15.8) <0.0001 2,824 (20.8) <0.0001
NHI 1st 8,684 (15.1) 5,971 (14.8) 1,950 (14.4)
NHI 2nd 4,419 (7.7) 2,976 (7.4) 943 (6.9)
NHI 3rd 6,595 (11.5) 4,540 (11.3) 1,434 (10.6)
NHI 4th 9,348 (16.3) 6,517 (16.2) 2,068 (15.2)
NHI 5th (richest) 19,848 (34.6) 13,945 (34.6)   4,362 (32.1)  
Type of long-term care benefits Institutional care 8,681 (15.1) 6,427 (15.9) <0.0001 1,950 (14.4) <0.0001
Home care 19,036 (33.2) 13,877 (34.4) 4,960 (36.5)
None 29,629 (51.7) 20,014 (49.6)   6,671 (49.1)  
Duration of dementia (years) <1 24,014 (41.9) 16,313 (40.5) <0.0001 5,388 (39.7) <0.0001
1–3 11,273 (19.7) 8,053 (20.0) 2,758 (20.3)
3–10 19,041 (33.2) 13,744 (34.1) 4,675 (34.4)
≥10 3,018 (5.3) 2,208 (5.5)   760 (5.6)  
CCI ≤2 18,898 (33.0) 10,984 (27.2) <0.0001 2,085 (15.4) <0.0001
3–4 20,579 (35.9) 15,021 (37.3) 4,903 (36.1)
≥5 17,869 (31.2) 14,313 (35.5)   6,593 (48.5)  

*Chi-square test of differences between patients with and without polypharmacy (5+)

**Chi-square test of differences between patients with and without excessive polypharmacy (10+)

NHI: National Health Insurance; CCI: Charlson comorbidity index